• OPEN AN ACCOUNT
Indian Indices
Nifty
22,502.00 35.90
(0.16%)
Sensex
74,005.94 88.91
( 0.12%)
Bank Nifty
48,199.50 83.85
( 0.17%)
Nifty IT
33,438.75 56.90
( 0.17%)
Global Indices
Nasdaq
16,685.97 -12.35
(-0.07%)
Dow Jones
40,003.59 134.21
(0.34%)
Hang Seng
19,636.22 82.61
(0.42%)
Nikkei 225
39,069.68 282.30
(0.73%)
Forex
USD-INR
83.47 0.01
(0.01%)
EUR-INR
90.76 0.22
(0.25%)
GBP-INR
105.79 0.36
(0.34%)
JPY-INR
0.54 0.00
(0.51%)

EQUITY - MARKET SCREENER

Bajaj Healthcare Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
539872
INE411U01027
114.5518581
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BAJAJHCARE
29.26
842.99
EPS(TTM)
Face Value()
Div & Yield %
10.44
5
0.33
 

bajaj healthcare ltd
Bajaj Healthcare appoints Dayashankar Patel as CFO
May 07,2024
Dayashankar Patel is a qualified Chartered Accountant with experience of more than 35 years in handling Internal Audit, Statutory Audit, Tax Audit and key Accounts and Finance functions.

He has successfully led and managed leading IPOs. In the past, he has worked with Companies like Pramara Promotions, Polycab India at various positions.

Bajaj Healthcare a leading manufacturer of APIs, intermediates and formulations. It has a strong presence globally in countries like Europe, USA, Australia, Africa, Middle East and South America.

The company had reported a consolidated net loss of Rs 2.20 crore in the quarter ended December 2023 as against net profit of Rs 11.05 crore during the previous quarter ended December 2022. Sales declined 18.10% to Rs 108.57 crore in Q3 FY24 over Q3 FY23.

The scrip declined 1.60% to end at Rs 316.95 on Monday, 6 May 2024.